An arrhythmia is a problem with the speed or rhythm of the heartbeat. During an arrhythmia, the heart can beat too fast, too slow, or with an irregular rhythm. A heartbeat that is too fast is called tachycardia. A heartbeat that is too slow is called bradycardia. Most arrhythmias are harmless, but some can be serious or even life threatening. When the heart rate is too slow, too fast, or irregular, the heart may not be able to pump enough blood to the body. Lack of blood flow can damage the brain, heart, and other organs.
During the "Novel Implications for Blood Flow and Vascular Dysfunction in Non-cardiovascular Related Disease" symposium at the APS Cardiovascular Aging: New Frontiers and Old Friends conference, researchers will present findings that emphasize the interaction between age-related cardiovascular dysfunction and disease whose risk increases with age.
A new study indicates that individuals with kidney disease have a higher risk of developing atrial fibrillation, or an irregular heartbeat.
Peerbridge Health has the vision to remove all wires associated with monitoring patients. For example, typically, electrocardiogram (ECG) monitoring systems have a multitude of wires. They started building a wireless ECG monitoring system called the Peerbridge Cor™ to improve ECG monitoring from the ground up.
Arrhythmia Alliance is calling on NHS England to reconsider its ‘Commissioning through Evaluation’ (CtE) process, which has left hundreds of patients with AF (Atrial Fibrillation) at serious risk of suffering a debilitating or life-threatening AF-related stroke.
There's good news when it comes to our heart's sinoatrial node (SAN), the body's natural pacemaker. Scientists at The Ohio State University Wexner Medical Center have shown the human SAN is hardwired with a backup system -- three diverse regions of pacemakers acting as batteries and up to five conduction pathways that act as wires to connect the signal to the atria.
A five per cent difference in favor of the 48 hours. This is the result of a study from Aarhus University that has spent several years examining the possible benefits of cooling down patients suffering cardiac arrest to 33°C for 48 hours, instead of the 24-hours that is standard practice in most places.
For patients with advanced, inoperable stage 3 lung cancer, concurrent chemotherapy and the specialized radiation treatment, proton therapy, offers improved survival compared to historical data for standard of care, according to a new study from The University of Texas MD Anderson Cancer Center.
Research published yesterday shows that the risk of developing an irregular heartbeat—atrial fibrillation— is considerably higher among people working more than 55 hours a week.
While there is solid evidence that adolescent overweight and obesity are associated with coronary heart disease (CHD) and stroke, less is known about the association between body mass index (BMI) and rarer cardiovascular diseases.
Royal Philips, a global health technology company, today announced the release of the IntelliVue X3 in Europe. Designed for portable, uninterrupted monitoring during in-hospital transport and at the bedside, IntelliVue X3 provides an intuitive smart-phone-style operation that quickly and easily enables continuous monitoring during transport for the most critical patients.
Pacemakers and other cardiac devices can help solve forensic cases, according to a study presented today at EHRA EUROPACE - CARDIOSTIM 2017. Devices revealed the time and cause of death in some cases where autopsy failed to do so.
Happitech, Arrhythmia Alliance and Bug Labs will announce the launch of the Heart for Heart e-health initiative. This initiative invites people to participate in the world’s largest crowdsourced heart health initiative by inviting them to contribute their heart rhythm data using the free Heart for Heart iPhone App.
A study by the University of Birmingham has revealed a treatment gap in patients suffering from a heart condition that causes an irregular or abnormally fast heartbeat.
Heart disease kills more than 600,000 Americans every year, which translates to more than one in every four deaths. Although lifestyle choices contribute to the disease, genetics play a major role.
Rush University Medical Center is offering a new, implantable cardiac device to reduce the risk of stroke in patients with atrial fibrillation, providing an alternative to the long-term use of blood thinners.
A wireless, battery-less pacemaker that can be implanted directly into a patient's heart is being introduced by researchers from Rice University and their colleagues at the Texas Heart Institute at the IEEE's International Microwave Symposium in Honolulu June 4-9.
Weighing oneself has become one of the most common morning rituals. However, your weight is not the only message that can be delivered by your bathroom scales: the team of researchers at Kaunas University of Technology Institute of Biomedical Engineering are developing the multifunctional scales, which can monitor your health and inform about potentially dangerous life conditions, such as arteriosclerosis or cardiac arrhythmia.
Congenital heart disease (CHD) includes a range of defects that occur in the heart which patients are born with, such as a hole in the heart's wall, a leaky valve or even an inversion in the heart's orientation. CHD was once a severe condition often resulting in early death, but now, more and more CHD patients are living long and healthy lives.
A new study has found that dementia rates increase when anticoagulation treatment is delayed for patients with atrial fibrillation, the most common heart arrhythmia in the world that affects more than 2.7 million American adults.
A study of more than 80,000 women with heart disease from 2003 to 2012 reveals that the prevalence of women with heart disease delivering babies increased by 24 percent over that 10-year period.